Future Technology, Future Treatments | DeltaV Life Sciences
4:33
Nikki Bishop and Chris White, a mucosal melanoma survivor, discuss how DeltaV manufacturing technology is helping bring tomorrow's life-saving treatments to patients faster.
Related Videos
In DeltaV
-
Play video Why Ecosystem Partnerships Matter in Life Sciences | DeltaV Life Sciences
Why Ecosystem Partnerships Matter in Life Sciences | DeltaV Life Sciences
Nikki Bishop, VP of Marketing for Life Sciences at Emerson, on why ecosystem partnerships help pharma and biotech get treatments to patients faster.
1:05
-
Play video A Patient's Impact Story: Chris White | DeltaV Life Sciences
A Patient's Impact Story: Chris White | DeltaV Life Sciences
Nikki Bishop, VP of Marketing for Life Sciences at Emerson, talks with Chris White, a mucosal melanoma survivor and patient advocate, about why life sciences manufacturing technology matters to real patients.
6:57
-
Play video 5 Critical Business Drivers for Life Sciences Manufacturers | DeltaV Life Sciences
5 Critical Business Drivers for Life Sciences Manufacturers | DeltaV Life Sciences
Nikki Bishop, VP of Marketing for Life Sciences at Emerson, walks through the business drivers shaping pharma and biotech manufacturing today: pipeline acceleration, flexible manufacturing, operational integrity, real-time release, and sustainable...
1:38
-
Play video Purpose-Built Solutions for Life Sciences Manufacturing | DeltaV Automation Platform
Purpose-Built Solutions for Life Sciences Manufacturing | DeltaV Automation Platform
Nikki Bishop, VP of Marketing for Life Sciences at Emerson, breaks down how purpose-built DeltaV solutions improve pharma and biotech manufacturing — including 10-80% more production capacity and less downtime with DeltaV RTS, batch review in 6 ho...
1:55
-
Play video Faster Tech Transfer: From 24 Months to 6 | DeltaV Life Sciences
Faster Tech Transfer: From 24 Months to 6 | DeltaV Life Sciences
Nikki Bishop, VP of Marketing for Life Sciences at Emerson, explains how DeltaV technology is helping pharma and biotech manufacturers cut tech transfer time from 24 months down to 6.
1:56
-
Play video Chris White's Patient Advocate Story | DeltaV Life Sciences
Chris White's Patient Advocate Story | DeltaV Life Sciences
Chris White, a mucosal melanoma survivor turned patient advocate, shares his story and why life sciences manufacturing innovation matters to patients.
2:23
